Acute lymphoblastic leukemia is a malignant neoplastic disease of lymphocytic origin.
Treatment regimens based on the different biology of ALL in acute lymphoblastic leukemia have been effective, with approximately 80% of children and 30% of adults achieving long-term disease-free survival with the potential for cure.